Mankind Pharma Ltd.

NSE: MANKIND | BSE: 543904 | ISIN: INE634S01028 | Industry: Pharmaceuticals
| Expensive Underperformer
2107.6000 -39.40 (-1.84%)
NSE Jan 23, 2026 15:31 PM
Volume: 406.7K
 

logo
Mankind Pharma Ltd.
23 Aug 2024, 12:00AM
2107.60
-1.84%
Motilal Oswal
MANKIND has a strategic roadmap for growth through expansion in high entry barrier innovative product launches in the chronic/consumer segment and other adjacencies, transitioning from sexual wellness to consumer wellness in the over-the counter (OTC) space.
Number of FII/FPI investors decreased from 627 to 575 in Dec 2025 qtr
More from Mankind Pharma Ltd.
Recommended